Related Experiment Videos
[The baby retraction reaction evaluation in pediatric diseases: a validity study]
Francisco Baptista Assumpção1, Tatiana Malheiros Assumpção
1Departamento de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Arquivos De Neuro-Psiquiatria
|February 4, 2003
Summary
The Behavior Assessment of Drug-related Symptoms (BADS) questionnaire shows no significant difference in withdrawal reactions between sick and healthy children. This validated scale is important for screening pediatric patients.
Area of Science:
- Pediatric Psychology
- Child Development
- Clinical Assessment
Background:
- Evaluating withdrawal reactions in young children requires considering their psychopathological context and developmental stage.
- Standardized instruments are crucial for accurate assessment.
Purpose of the Study:
- To validate the Behavior Assessment of Drug-related Symptoms (BADS) questionnaire.
- To assess withdrawal reactions in pediatric patients aged 0-2 years.
- To compare withdrawal reactions in sick versus healthy children.
Main Methods:
- The BADS questionnaire was administered to 35 children (0-2 years) with pediatric diseases.
- Results were compared to a previous study of 90 healthy children.
- Independent t-test was used for statistical analysis.
Main Results:
- Mean BADS scores were 5.90 ± 2.57 for normal children and 6.37 ± 4.83 for sick children.
- The difference in scores was not statistically significant (p=0.651) at a 5% significance level.
- Withdrawal reactions in sick children did not significantly differ from those in normal children.
Conclusions:
- The BADS questionnaire is a valid screening instrument for assessing withdrawal reactions in young children.
- The scale's findings suggest that illness does not significantly alter withdrawal reactions in this age group.
- Further research may explore specific pediatric conditions and their impact on withdrawal symptoms.